Impaired corticostriatal LTP and depotentiation following iPLA2 inhibition is restored following acute application of DHA

Brain Research Bulletin

Volumn 111, Issue , 2015, Pages 69-75

  Mazzocchi Jones, David ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Depotentiation; Docosahexaenoic acid; Omega 3; Striatum; Synaptic plasticity

Indexed keywords

BROMOENOL LACTONE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2; DOCOSAHEXAENOIC ACID; 6-(BROMOMETHYLENE)TETRAHYDRO-3-(1-NAPHTHALENEYL)-2H-PYRAN-2-ONE; NAPHTHALENE DERIVATIVE; PHOSPHOLIPASE A2 GROUP VI; PLA2G6 PROTEIN, MOUSE; PYRONE DERIVATIVE;

ADULT; ANIMAL CELL; ARTICLE; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME INHIBITION; FACILITATION; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MOUSE; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NONHUMAN; PAIRED PULSE FACILITATION; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; CORPUS STRIATUM; DRUG EFFECTS; ELECTROSTIMULATION; PHYSIOLOGY;

ANIMALS; CEREBRAL CORTEX; CORPUS STRIATUM; DOCOSAHEXAENOIC ACIDS; ELECTRIC STIMULATION; GROUP VI PHOSPHOLIPASES A2; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MICE; NAPHTHALENES; PYRONES;

EID: 84921456696     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.12.010     Document Type: Article

References (41)

1. Aires V., Hichami A., Filomenko R., Plé A., Rébé C., Bettaieb A., Khan N.A. Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol. Pharmacol. 2007, 72:1545-1556. 10.1124/mol.107.039792.
2. Anderson W.W., Collingridge G.L. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J. Neurosci. Methods 2007, 162:346-356. 10.1016/j.jneumeth.2006.12.018.
3. Bang H.O., Dyerberg J., Hjøorne N. The composition of food consumed by Greenland Eskimos. Acta Med. Scand. 1976, 200:69-73.
4. Bauer I., Crewther S., Pipingas A., Sellick L., Crewther D. Does omega-3 fatty acid supplementation enhance neural efficiency? A review of the literature. Hum. Psychopharmacol. 2014, 29:8-18. 10.1002/hup.2370.
5. Bauer I., Hughes M., Rowsell R., Cockerell R., Pipingas A., Crewther S., Crewther D. Omega-3 supplementation improves cognition and modifies brain activation in young adults. Hum. Psychopharmacol. 2014, 29:133-144. 10.1002/hup.2379.
6. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39. 10.1038/361031a0.
7. Brown W.J., Chambers K., Doody A. Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 2003, 4:214-221.
8. Calabresi P., Centonze D., Gubellini P., Marfia G.A., Pisani A., Sancesario G., Bernardi G. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol. 2000, 61:231-265.
9. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels. Eur. J. Neurosci. 1992, 4:929-935.
10. Chabot C., Gagné J., Giguère C., Bernard J., Baudry M., Massicotte G. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Hippocampus 1998, 8:299-309. doi:10.1002/(SICI)1098-1063(1998)8:3<299::AID-HIPO11>3.0.CO;2-W.
11. Davis S., Butcher S.P., Morris R.G. The NMDA receptor antagonist d-2-amino-5-phosphonopentanoate (d-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J. Neurosci. 1992, 12:21-34.
12. de Groot R.H.M., Hornstra G., Jolles J. Exploratory study into the relation between plasma phospholipid fatty acid status and cognitive performance. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76:165-172. 10.1016/j.plefa.2007.01.001.
13. de Urquiza A.M., Liu S., Sjöberg M., Zetterström R.H., Griffiths W., Sjövall J., Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290:2140-2144.
14. Denys A., Aires V., Hichami A., Khan N.A. Thapsigargin-stimulated MAP kinase phosphorylation via CRAC channels and PLD activation: inhibitory action of docosahexaenoic acid. FEBS Lett. 2004, 564:177-182. 10.1016/S0014-5793(04)00361-8.
15. Diamond J.S. Neuronal glutamate transporters limit activation of NMDA receptors by neurotransmitter spillover on CA1 pyramidal cells. J. Neurosci. 2001, 21:8328-8338.
16. Dyall S.C., Michael G.J., Whelpton R., Scott A.G., Michael-Titus A.T. Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol. Aging 2007, 28:424-439. 10.1016/j.neurobiolaging.2006.01.002.
17. Exton J.H. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta 1994, 1212:26-42.
18. Farooqui A.A., Horrocks L.A. Brain phospholipases A2: a perspective on the history. Prostaglandins Leukot. Essent. Fatty Acids 2004, 71:161-169. 10.1016/j.plefa.2004.03.004.
19. Farooqui A.A., Horrocks L.A., Farooqui T. Deacylation and reacylation of neural membrane glycerophospholipids. J. Mol. Neurosci. 2000, 14:123-135.
20. Fujita S., Ikegaya Y., Nishikawa M., Nishiyama N., Matsuki N. Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br. J. Pharmacol. 2001, 132:1417-1422. 10.1038/sj.bjp.0703970.
21. Hölscher C., Canevari L., Richter-Levin G. Inhibitors of PLA2 and NO synthase cooperate in producing amnesia of a spatial task. Neuroreport 1995, 6:730-732.
22. Hölscher C., Rose S.P. Inhibitors of phospholipase A2 produce amnesia for a passive avoidance task in the chick. Behav. Neural Biol. 1994, 61:225-232.
23. Huang C.C., Liang Y.C., Hsu K.S. Characterization of the mechanism underlying the reversal of long term potentiation by low frequency stimulation at hippocampal CA1 synapses. J. Biol. Chem. 2001, 276:48108-48117. 10.1074/jbc.M106388200.
24. Kudo I., Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 2002, 68-69:3-58.
25. Mashimo M., Hirabayashi T., Murayama T., Shimizu T. Cytosolic PLA2(alpha) activation in Purkinje neurons and its role in AMPA-receptor trafficking. J. Cell. Sci. 2008, 121:3015-3024. 10.1242/jcs.032987.
26. Massicotte G., Oliver M.W., Lynch G., Baudry M. Effect of bromophenacyl bromide, a phospholipase A2 inhibitor, on the induction and maintenance of LTP in hippocampal slices. Brain Res. 1990, 537:49-53.
27. Mazzocchi-Jones D., Doebroessy M., Dunnett S.B. Embryonic striatal grafts restore bi-directional synaptic plasticity in a rodent model of Huntington's disease. Eur. J. Neurosci. 2009, 30:2134-2142. 10.1111/j.1460-9568.2009.07006.x.
28. Mazzocchi-Jones D., Doebroessy M., Dunnett S.B. Environmental enrichment facilitates long-term potentiation in embryonic striatal grafts. Neurorehabil. Neural Repair 2011, 25:548-557. 10.1177/1545968311402090.
29. Murakami M., Shimbara S., Kambe T., Kuwata H., Winstead M.V., Tischfield J.A., Kudo I. The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 1998, 273:14411-14423.
30. Oregan M.H., Perkins L.M., Phillis J.W. Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex. Neurosci. Lett. 1995, 193:85-88.
31. Picconi B., Centonze D., Håkansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., Calabresi P. Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat. Neurosci. 2003, 6:501-506. 10.1038/nn1040.
32. Rapoport S.I., Chang M.C., Spector A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 2001, 42:678-685.
33. Scott B.L., Bazan N.G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:2903-2907.
34. Scott D.L., White S.P., Otwinowski Z., Yuan W., Gelb M.H., Sigler P.B. Interfacial catalysis: the mechanism of phospholipase A2. Science 1990, 250:1541-1546.
35. Siddiqui R.A., Jenski L.J., Harvey K.A., Wiesehan J.D., Stillwell W., Zaloga G.P. Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem. J. 2003, 371:621-629. 10.1042/BJ20021667.
36. Silva A.J., Paylor R., Wehner J.M., Tonegawa S. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 1992, 257:206-211.
37. Silva A.J., Stevens C.F., Tonegawa S., Wang Y. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 1992, 257:201-206.
38. Strokin M., Sergeeva M., Reiser G. Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br. J. Pharmacol. 2003, 139:1014-1022. 10.1038/sj.bjp.0705326.
39. Titova O.E., Sjögren P., Brooks S.J., Kullberg J., Ax E., Kilander L., Riserus U., Cederholm T., Larsson E.-M., Johansson L., Ahlström H., Lind L., Schiöth H.B., Benedict C. Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly. Age (Dordr) 2013, 35:1495-1505. 10.1007/s11357-012-9453-3.
40. Young C., Gean P.W., Chiou L.C., Shen Y.Z. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 2000, 37:90-94. doi:10.1002/1098-2396(200008)37:2<90::AID-SYN2>3.0.CO;2-Z.
41. Young C., Gean P.W., Wu S.P., Lin C.H., Shen Y.Z. Cancellation of low-frequency stimulation-induced long-term depression by docosahexaenoic acid in the rat hippocampus. Neurosci. Lett. 1998, 247:198-200.